ImmunityBio, Inc. (IBRX) stock declined 10.79% amid market plunge after Federal Chairman's comments.
From Yahoo Finance: 2025-04-17 00:05:00
Stocks plunged on Wednesday after Federal Chairman Jerome Powell’s comments on the US economy. The Nasdaq dropped 3.07%, S&P 500 fell 2.24%, and Dow Jones was down 1.73%. IBRX declined 10.79% amid market decline. The company submitted a biologic license application for its immunotherapy Anktiva. IBRX is focusing on global expansion, including a marketing authorization request in Europe.
Read more: Why ImmunityBio, Inc. (IBRX) Declined on Wednesday